MORE►
BioLabs at Pegasus Park
Early-stage oncology companies will have the opportunity to compete for lab and office space at BioLabs Pegasus Park, a $25,000 cash prize, and invaluable guidance from industry professionals. [Photo: BioLabs at Pegasus Park]
American Cancer Society’s BrightEdge Golden Ticket Pitch Competition to Be Held at Pegasus Park
by Lance Murray | Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
by Quincy Preston and Lance Murray |
Sep 30, 2024
According to an economic impact report by The Perryman Group, the 26-acre Pegasus Park campus, once fully built out under its master plan, is projected to generate $1.9 billion in annual gross product and create over 15,000 jobs.
Bridge Labs, the latest addition to the Pegasus Park campus, is designed to provide high-quality, flexible lab and office space for growth-stage biotech companies. "It's one-of-a-kind in the region," said Nicole Small, CEO of Lyda Hill Philanthropies.
Bridge Labs, the latest addition to the Pegasus Park campus, is designed to provide high-quality, flexible lab and office space for growth-stage biotech companies. "It's one-of-a-kind in the region," said Nicole Small, CEO of Lyda Hill Philanthropies.
MORE►
by Lance Murray |
Sep 17, 2024
Baltimore-based Secretome has a presence at BioLabs at Pegasus Park in Dallas. The biotech company is at the forefront of developing "revolutionary solutions" aimed at harnessing the power of secretomes, naturally occurring molecules that promote healing and regeneration, HEST said.
MORE►
by Lance Murray |
Jun 15, 2023
The $110 million, 135,000 square-foot expansion at Pegasus Park—a regional hub for life sciences and biotechnology in North Texas—will offer prebuilt lab suites with the tools and flexible space needed for growth-stage life sciences entrepreneurs and companies. Demolition is underway and construction on Bridge Labs is set to begin soon, developers said.
MORE►
[Image: privetik/istockphoto]
Startup to Storefront: SkinStasis Launches ‘Revolutionary’ Skin Care Product Out of BioLabs at Pegasus Park
by Quincy Preston and David Seeley | Dec 19, 2022
Co-founders Paul Stewart and Frank Murdock started up SkinStasis Skin Care earlier this year to meet "a big unmet need" in the cold sore/herpes virus field, where they say there's been "no real new pharmaceutical development" for over 20 years.
Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
MORE►
